Antiretroviral News and Research

RSS

AHF: Gilead's campaign for FDA approval of Truvada leads to black marketing in Florida

Today AIDS Healthcare Foundation (AHF) decried the fact that the recent campaign by Gilead Sciences Inc. to obtain approval by the U.S. Food & Drug Administration for Truvada as PrEP (pre-exposure prophylaxis) has led to a "black market" for the drug in Florida.

20 Aug 2011

PrEP raises questions regarding 'risk disinhibition' and drug resistance

Nature News reports on "the possibility of unintended public-health consequences" of pre-exposure prophylaxis (PrEP) for HIV and pharmaceutical company Gilead's plan to ask the FDA to evaluate its combination antiretroviral (ARV) drug Truvada for use in healthy people.

18 Aug 2011

Insight into how HIV reservoirs may form

Much like cities organize contingency plans and supplies for emergencies, chronic infectious diseases like HIV form reservoirs that ensure their survival in adverse conditions. But these reservoirs-small populations of viruses or bacteria of a specific type that persist despite attack by the immune system or drug treatment-are not always well understood.

18 Aug 2011

South Africa expands AIDS program to allow earlier ARV treatment

The South African National AIDS Council (SANAC) on Saturday endorsed a new National Health Council policy to expand the country's AIDS program "to allow people living with HIV to start antiretroviral [ARV] treatment earlier" by raising the CD4 count necessary to access treatment from 200 to 350, Agence France-Presse reports.

16 Aug 2011

FDA approves Gilead's Complera for treatment of HIV-1 infection

Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Complera, a complete single-tablet regimen for the treatment of HIV-1 infection in treatment-naïve adults.

11 Aug 2011

Economic slowdown should not hamper global fund donations

With the new knowledge that providing antiretroviral treatment to people living with HIV would "contribut[e] to a sharp slowdown in the spread of the virus," "scaling up treatment now may prove to be the least expensive option if we want to bring this deadly pandemic, which still infects 1.8 million people every year, under control," Michel Kazatchkine, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria writes in the Guardian's "Poverty Matters Blog."

6 Aug 2011

New research highlights urgent need to develop specific guidelines for HIV-infected children

Children with HIV have persistently high levels of cholesterol and other lipids during treatment with antiretroviral medications, according to a pair of studies in JAIDS: Journal of Acquired Immune Deficiency Syndromes.

4 Aug 2011

Viewpoints: Geithner, Bowles, Simpson, Ryan, Vladeck, Wilensky on health spending and the deficit

The agreement sets up a powerful mechanism for agreement on tax reforms to strengthen growth, and entitlement reforms to strengthen programs such as Medicare. A congressional committee with fast-track authority will have a Nov. 23 deadline to recommend a balanced package of long-term reforms to produce $1.5 trillion in additional deficit reduction.

4 Aug 2011

PBS NewsHour profiles projects competing in saving lives at birth challenge

PBS NewsHour on Monday profiled five projects to improve maternal and child health that are competing for a share of $14 million in research grants through the Saving Lives at Birth challenge.

3 Aug 2011

Reducing commodity costs for ARVs could mean providing treatment to millions more people

"Reducing commodity costs for antiretroviral drugs by a mere five to 10 percent can represent hundreds of millions of dollars in savings for the global community. In turn these savings translate into millions of more patients who can receive access to life-saving treatment," David de Ferranti, president of Results for Development Institute (R4D), and Kanika Bahl, managing director at R4D, write in a Huffington Post opinion piece.

3 Aug 2011

Demonstrators in Swaziland express concern over possible antiretroviral shortages

More than 3,000 demonstrators gathered across Swaziland on Thursday for a second day of protests over the king's handling of an economic crisis that they say is causing a shortage of medical supplies, including antiretroviral therapy, the Associated Press/Washington Post reports (7/28).

30 Jul 2011

Political, economic tensions in Malawi threaten new HIV/AIDS strategy

In a guest post on the GlobalPost's "Global Pulse" blog, Janet Fleischman, a senior associate at the CSIS Global Health Policy Center, describes the Malawian government's "plans to launch a 'test and treat' program in which all HIV-infected pregnant women will immediately be put on antiretroviral treatment drugs for life."

30 Jul 2011

Merck reports worldwide sales of $12.2 billion for second quarter 2011

Merck, known as MSD outside the United States and Canada, today announced financial results for the second quarter of 2011.

29 Jul 2011

Early initiation of HIV therapy would save money, lives of South Africans

If the South African government followed a recent recommendation by the World Health Organization to start antiretroviral therapy (ART) for HIV-infected residents earlier in the progress of the disease, the policy shift would start saving the country money after 16 years and would extend thousands of lives for dozens of years, according to a new study.

27 Jul 2011

Guidance needed on recent HIV prevention findings

"In the absence of the anticipated guidance from WHO, the euphoria felt by participants at Rome that the latest science can allow us for the first time to consider eliminating HIV was tempered by utter confusion among program managers as to what to do next," Nathan Ford, medical coordinator for Medecins Sans Frontiere's International Campaign for Access to Essential Medicines, writes in the PLoS "Speaking of Medicine" blog.

25 Jul 2011

Medicines Patent Pool can help many but has potential limitations for AIDS drug access in middle-income countries

In a post on the New York Times' "Opinionator" blog, author and journalist Tina Rosenberg writes about the Medicines Patent Pool (MPP) and describes how it can help purchase AIDS drugs for "vast numbers of people."

25 Jul 2011

Circumcision prevents HIV transmission & cocktail of anti-HIV drugs prolong life

Reports came in last Wednesday that circumcision reduces transmission of HIV, in regions where transmission is high. To researchers, this procedure proves to be a cost-effective way to handle the pandemic. In South Africa, a study reported that men with circumcisions reduced new HIV infections by 76%.

24 Jul 2011

Boosted REYATAZ shows durable viral suppression in women with HIV

Bristol-Myers Squibb Company announced results from a long-term, retrospective, European cohort study, which included 1,294 antiretroviral (ARV)-experienced patients from Germany, France and Sweden, that were presented today at the Sixth International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention.

21 Jul 2011

IAS, UIPHP to launch VKC for injecting drug users living with HIV

As a part of its new initiative, Expanding Access to Opioid Substitution Therapy (OST) for People Who Inject Drugs in Eastern Europe and Central Asia (EECA), the International AIDS Society (IAS) will launch a Virtual Knowledge Centre (VKC) in partnership with the Ukrainian Institute on Public Health Policy.

21 Jul 2011

New trends in HIV cure research presented at IAS 2011

Researchers speaking on the final day of the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) have focused on the growing interest in the scientific path to an HIV Cure.

20 Jul 2011